• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cubist Pharmaceuticals Inc

+ Add to Watchlist

CBST:US

67.2700 USD 0.8900 1.34%

As of 11:29:34 ET on 04/24/2014.

Snapshot for Cubist Pharmaceuticals Inc (CBST)

Open: 66.5500 Day's Range: 65.2082 - 67.5000 Volume: 261,454
Previous Close: 66.3800 52wk Range: 44.4600 - 82.1200 1-Yr Rtn: +45.73%

Stock Chart for CBST

No chart data available.
  • CBST:US 67.2500
  • 1D
  • 1M
  • 1Y
66.3800
Interactive CBST Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBST

Current P/E Ratio (ttm) 59.5145
Estimated P/E(12/2014) 40.2059
Relative P/E vs. SPX 3.5135
Earnings Per Share (USD) (ttm) 1.1154
Est. EPS (USD) (12/2014) 1.6510
Est. PEG Ratio 1.6411
Market Cap (M USD) 4,998.35
Shares Outstanding (M) 75.30
30 Day Average Volume 883,991
Price/Book (mrq) 3.4963
Price/Sale (ttm) 4.3681
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBST

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CBST

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment.

Michael Weston Bonney "Mike"Chief Executive OfficerRobert J Perez "Rob"President/COO
Steven C Gilman "Steve"Exec VP:Research & DevelopmentMichael Tomsicek "Mike"Senior VP/CFO
More Company Profile & Key Executives for CBST

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil